Clinical Trial Update: Efficacy of FDC Regimen of Dapagliflozin/Metformin Compared to Co-administered Dual Therapy on Glycemic Control, Satisfaction and Adherence in Chinese Patients With T2DM [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the efficacy of a fixed-dose combination of dapagliflozin/metformin versus separately administered dapagliflozin and metformin in Chine…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Dapagliflozin (dapagliflozin)
• Dapagliflozin/metformin (dapagliflozin/metformin)
• metformin (metformin)

Snippet

Sponsor: AstraZeneca | Conditions: Type 2 Diabetes Mellitus (T2DM) | Phase 4 | Status: COMPLETED